Evidence map›Paper›PMID 39339388›Full record

ArticleMolecules (Basel, Switzerland)2024

Heterologous Expression of Ketoreductase

Wanping Chen, Lei Sun, Xinwei Wu, Zhenni Xu, Chin-Yu Chen, Sitong Liu, Haibin Chen, Baoguo Sun, Mingxin Dong

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wanping ChenSchool of Pharmacy, Qingdao University, Qingdao 266021, China.
Lei SunEnzymaster (Ningbo) Bio-Engineering Co., Ltd., Ningbo 315100, China.
Xinwei WuEnzymaster (Ningbo) Bio-Engineering Co., Ltd., Ningbo 315100, China.
Zhenni XuState Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China.
Chin-Yu ChenState Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China.
Sitong LiuEnzymaster (Ningbo) Bio-Engineering Co., Ltd., Ningbo 315100, China.
Haibin ChenEnzymaster (Ningbo) Bio-Engineering Co., Ltd., Ningbo 315100, China.ORCID 0000-0003-2589-7347
Baoguo SunEnzymaster (Ningbo) Bio-Engineering Co., Ltd., Ningbo 315100, China.
Mingxin DongSchool of Pharmacy, Qingdao University, Qingdao 266021, China.

Funding

Postdoctoral Innovation Project of Shandong Province No.DCX-ZG-202203010Science and Technology Research Project of Education Depart-471 ment of Hubei Province Q20221002
6 · The paper itself

Abstract

(

Indexed as

Butylene GlycolsAlcohol OxidoreductasesFermentationGene ExpressionHydrogen-Ion ConcentrationMutationRecombinant ProteinsSaccharomycetales1,3-butylene glycolAlcohol OxidoreductasesButylene GlycolsRecombinant ProteinsChKRED20high-density fermentationmulti-copymutant M12P. pastoris(R)-1, 3-BDOstereoselectivity

Identifiers

PMID39339388
PMCPMC11433769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.